Zimmer Biomet Holdings shared its Q3 results, showing a 3.1% rise in sales and changing its 2026 growth forecast.

Nov 4, 2026, 9:49 AM ETResultsRead the original at Benzinga

Good for ZBH

Zimmer Biomet raised its 2026 sales and adjusted profit forecasts, and Q3 sales grew 3.1%. China distributor changes and knee challenges weigh against this, but growth in hips and other businesses supports the stronger outlook.

ZBH · Zimmer Biomet Holdings

AI read · Good for ZBH

The AI's read

Growth in hips and other business lines, along with strength in technology and data, points to gains from newer products and a broader business. China distributor changes weighed on sales, and the knee business still faced challenges. The company described the China effect as one-time, so the gains across several areas and higher forecasts carry more weight.

Get alerts for ZBH

Follow Zimmer Biomet Holdings (ZBH) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ZBH

Free on the App Store and Google Play, or on the web.